Ann: Positive Results from IHL-675 (ARDS) animal study, page-90

Bosco used to be a holder I think most people know that.

He has posed some questions, some I have even asked management about before.
Some are better questions than others. Even the valid questions that were posed we already have gotten answers to.

One of them was regarding the OSA Trial, whether it was stay at home, who would validate the trial etc.
As per the most recent ann all concerns have been quelled, and rather savagely too. It is a massive upgrade from the previous framework in fact.

I know leading up to this ann we had a variety of views as to how the market would view this ann if successful.
It's Stage 1, proof that the components work. Big news but IMO it was never going to be the rocket ann. That would come off the back of a Stage 2 success and FDA approval for emergency access.

I think expectations differed across the board as to what this ann meant, and IMO most today that are selling are stale holders and intraday traders.

This is a fantastic first step and the first actual point of clinical success for the IHL team. If this was considered dodgy in the slightest firstly it wouldn't even have gapped up so high or even gapped up at all and secondly it would've been sold down into oblivion. Come on.